Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1963476Generated: October 30, 2026

Hydrochloric Acid → cis-Methyl 4-(3-ethoxy-3-oxopropanoyl)-2-(2-fluoro-4-(trifluoromethyl)phenyl)piperidine-1-carboxylate

https://huagongshe.com/reaction/1963476

Reaction equation

Participants

RoleNameHCIDCharge
ReactantHydrochloric AcidHCID 313—
Reactant1,1'-CarbonyldiimidazoleHCID 68263—
ReactantPotassium ethyl malonateHCID 3446434—
ReactantMagnesium ChlorideHCID 5360315—
Reactant2-(2-Fluoro-4-(trifluoromethyl)phenyl)-1-(methoxycarbonyl)piperidine-4-carboxylic acidHCID 66731558—
SolventWaterHCID 962—
Solventtert-Butyl methyl etherHCID 15413—
SolventHCID 178479889HCID 178479889—
Productcis-Methyl 4-(3-ethoxy-3-oxopropanoyl)-2-(2-fluoro-4-(trifluoromethyl)phenyl)piperidine-1-carboxylateHCID 13173043149%

Reaction Steps

2-(2-fluoro-4-(trifluoromethyl)phenyl)-1-(methoxycarbonyl)piperidine-4-carboxylic acid (4.82 g, 13.80 mmol) was dissolved in methyl THF (120 mL), then di(1H-imidazol-1-yl)methanone (4.03 g, 24.84 mmol) was added. The mixture was stirred at room temperature under nitrogen for 5 h (flask 1). In a separate flask potassium 3-ethoxy-3-oxopropanoate (4.23 g, 24.84 mmol) was suspended in methyl THF (120 mL), then magnesium chloride (2.365 g, 24.84 mmol) was added. The suspension was stirred at 50° C. under nitrogen for 5 h using a large magnetic stirring bar (flask 2). The contents of flask 1 was transferred into flask 2. The resulting white suspension was stirred under nitrogen at room temperature overnight. The mixture was acidified to pH 1 with 3.8 M HCl, then MTBE (50 mL) and water (50 mL) was added. The phases were separated and the organic layer was washed with water, satd NaHCO3 and brine. The organic layer was dried over Na2SO4, filtered and evaporated leaving a slightly yellow oil. The residue was purified by chromatography on silica (Biotage (340 g) with a 1 CV EtOAc in heptane (20%) followed by a gradient of 20-60% EtOAc in n-heptane (8 CV). The column was conditioned at 20% EtOAc in -n-heptane (1 CV)). Trans-methyl 4-(3-ethoxy-3-oxopropanoyl)-2-(2-fluoro-4-(trifluoromethyl)phenyl) piperidine-1-carboxylate (413 mg, 7%) and cis-methyl 4-(3-ethoxy-3-oxopropanoyl)-2-(2-fluoro-4-(trifluoromethyl)-phenyl)piperidine-1-carboxylate (2.83 g, 49%) were isolated. Cis-isomer: 1H NMR (400 MHz, cdcl3) δ 1.22-1.32 (m, 3H), 1.81-1.96 (m, 2H), 2.06-2.18 (m, 1H), 2.27-2.36 (m, 1H), 2.87-2.97 (m, 1H), 3.34-3.51 (m, 3H), 3.58-3.66 (m, 3H), 4.14-4.23 (m, 3H), 5.15 (dd, 1H), 7.25-7.40 (m, 3H). MS m/z 420 (M+H)+. Trans-isomer: 1H NMR (400 MHz, cdcl3) δ 1.18-1.31 (m, 3H), 1.58-1.72 (m, 1H), 1.87-2.06 (m, 2H), 2.40-2.60 (m, 2H), 3.17 (dt, 1H), 3.45 (s, 2H), 3.73 (s, br., 3H), 4.08-4.23 (m, 2H), 4.34 (s, br., 1H), 5.75 (s, br., 1H), 7.22-7.43 (m, 3H). MS m/z 420 (M+H)+

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08415378B2
Source datasetuspto-grants-2013_04
ORD IDord-09e87f18510e45e5ab220a836deb76de
Source noteuspto-grants-2013_04